Home > Journals > Minerva Gastroenterology > Past Issues > Minerva Gastroenterology 2022 September;68(3) > Minerva Gastroenterology 2022 September;68(3):363-5

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

LETTERS TO THE EDITOR   Free accessfree

Minerva Gastroenterology 2022 September;68(3):363-5

DOI: 10.23736/S2724-5985.21.03041-2

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

MiR-34a targets SNAI1 and is essential for 5-hydroxytryptamine induced epithelial mesenchymal transition in liver cancer

Zhixin WANG 1, Wen WANG 1, Liuxin ZHOU 1, Li REN 1, Runchen MIAO 2, Kai QU 2, Bin REN 1, Wenhao YU 1, Haijiu WANG 1, Chang LIU 2, Haining FAN 1

1 Department of Hepatopancreatobiliary Surgery, Affiliated Hospital of Qinghai University, Xining, China; 2 Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China



top of page